P15: IMPROVING THE OUTCOME OF FETAL PROCEDURES

P15.01
Procedure-to-delivery interval after late amniocentesis (28 and 33 weeks): is there a rationale in giving glucocorticoids prior to the procedure? Objectives: The administration of prophylactic glucosteroids as a routine prior to the late amniocentesis (AC) -28-33 weeks-is controversial once there is scarce data about the incidence of preterm delivery and complications related to the procedure. The aims of this study were a) to estimate the procedure-to-delivery interval (PDI) and the incidence of procedure-related complications; b) to compare the early neonatal morbidity rate between patients which have received or not antenatal steroids (ACS) prior to the procedure and had preterm deliveries. Methods: This retrospective study enrolled 202 patients who have underwent late diagnostic AC. Patients with high risk for preterm delivery were excluded (except for polihydramnion). Patients were assigned into 2 groups according to administration or not of ACS prior to the AC. Patient data was collected from hospital files. Main parameters for analysis were: 1) PDI; 2) Mean gestational age at delivery; 3) Incidence of delivery within 24, 48 hours and two weeks; 4) Incidence of delivery below 34 weeks; 5) early neonatal outcome and complications. Results: Group 1 comprised 109 patients and group 2, 93. The mean PDI was 48.9 days. Only 1 patient delivered within 24h after procedure due to placental abruptio, 1 patient delivered within 48 hours due to chorioamnionitis. In 97.5% of the cases both the PDI was > than 2 weeks and delivery occurred after 34 weeks. The incidence of preterm birth<37 weeks was 7.9% and <34 weeks was 1.98%. The same rate was observed for cases with PDI < 14 days. No differences for early neonatal morbidity parameters were found (p=0.076). Conclusions: Late AC was related to a low incidence of birth before 34 weeks. The mean procedure-to-delivery interval was 49 days. Neonatal complications rates were similar to the general population, regardless of administration of antenatal steroids. We speculate that there is no benefit in routine prophylactic administration of ACS prior to the procedure. Further studies are needed to vouch the present data. 
